This MOFO is 100% opposite elon musk. i will not quote because its not verbatim, but when elon was asked about stock price, he said make good products. Consumers will be happy then investors will be happy. To me, that is profound wisdom that is lost on may higher ups, these days. when whats his nuts was asked, he kept pumping investor confidence. Not consumer confidence.that to me is the number one colossal red flag. He wants to out elon, elon, but speaks as a penny stock CEO. Elon speaks with little regard to the market. When he does, he trolls. Whats his nuts wants to copy everything elon does, except not as well, and claim to beat out do him at him. Thats actually creepy. Its very creepy. Its one thing to think it. But another to proclaim it to the world. He is crazier than i am. i would not be surprised to see him on some ponzi/house of cards, show 5 yrs from now.
Kodak is a pawn company. Unless my perception is entirely broken, it has been taken over by some people with plans to manipulate it for their own gain. It's small enough that a medium fish can own it outright and was once big enough that it is publicly traded. It has enough name recognition to attract investors who might think film is coming back. It is all there. This might intrigue some people but I wouldn't buy Kodak with Paul Simon's money. Somebody is going to make out well on this thing, before they bury it, but it is unlikely to be retail investors without inside knowledge. Retail investors will be the donors. Suffice to say, I have no plans to own Kodak now or in the future.
anybody noticing this? skyrocketed last 2 days. lawyers say deal is legal. Kodak Stock Soars After a Report Allays Worries on Some Key Investor Issues -- Barrons.com 10:25 am ET September 16, 2020 (Dow Jones) Print By Al Root Stock in former photography giant Eastman Kodak has held a lot of drama for investors of late. Shares soared more than 200% on July 28 and more than 300% on July 29. Shares were up another 56% Wednesday morning after a report prepared for the company and issued Tuesday found no evidence of insider trading by management or major Kodak (ticker: KODK) shareholders ahead of the announcement in July of a potential $765 million loan for a new drug-ingredient business. The report said the company mishandled an options grant to management.
light volume this morning. my suggestion is a name change if they are going to move into drugs. those of us who have been on the planet a while will always think camera and film when we hear kodak.
